Arrieta follows the heart to find a protein function
When Adrian Arrieta started undergraduate studies in molecular toxicology at the University of California, Berkeley, he anticipated a career in drug development and pharmacology. However, a comparison of normal and cancerous human karyotypes in a genetics class sparked his interest in molecular mechanisms of disease.
Arrieta joined Christopher Glembotski's lab at San Diego State University for his doctoral research, working on the premise that a tumor microenvironment has a high degree of protein misfolding and shares characteristics with a heart undergoing ischemia. Upregulated genes in cancer cells might provide a clue to which proteins in the heart respond protectively to stress.
Arrieta and his team's research was published in the Journal of Biological Chemistry. A collaborative environment was key to his success, he said; the lab had to develop new assays and techniques. "We really had to start from the ground up," he said. "Everyone in the author block did something to make this happen."
Arrieta is now a postdoc at the David Geffen School of Medicine at UCLA in Thomas Vondriska's lab. Arrieta met Vondriska during a talk on Arrieta's paper at a conference on cardiac regulatory mechanisms. The two were intrigued by each other's research, and Arrieta is now investigating protein quality control in the context of chromatin dynamics in the heart.
He's excited to be back in LA, where he grew up, because he can be with his family and enjoy home-cooked meals. "My mother told me that when I was little, I told her I was going to work at UCLA," he said. "Now, here I am — full circle."
Finding the function of an ER-resident chaperone in the heart
After cardiac ischemia, reperfusion injury can occur when blood returns to the tissue. Ischemia/reperfusion, or I/R, disrupts protein folding and post-translational modification in the endoplasmic reticulum, causing loss of protein function and activating the ER stress response.
Mesencephalic astrocyte-derived neurotrophic factor, or MANF, is part of a gene program regulated by an ER stress response transcription factor. For more than a decade, researchers knew that MANF was upregulated in models of heart disease but didn't know its exact function. MANF bears no structural similarity to other ER proteins, and this got Adrian Arrieta wondering. "If it doesn't look like anything else that's been studied in the heart or any other tissue, it must be doing something really unique," he said. "That was the draw."
Arrieta and his colleagues in the Glembotski lab at San Diego State did experiments spanning techniques and specialties to deduce MANF function. They developed a knockdown mouse model to study MANF in both cells and mouse hearts. Lack of MANF expression in the heart increases cardiac damage during I/R injury, they found, and restoring MANF expression can reverse those effects. MANF also improved ER proteostasis during reperfusion injury.
The team found that MANF acts in response to reductive, not oxidative, stress during reperfusion injury and isolated its function as an ER-resident chaperone. Finally, by generating and studying a mutant version of the protein, Arrieta determined that conserved cysteine residues in the MANF molecule are required for its chaperone function. MANF's lack of structural homology remains a question for future research.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles
Meet the 2025 SOC grant awardees
Five science outreach and communication projects received up to $1,000 from ASBMB to promote the understanding of molecular life science.
Unraveling cancer’s spaghetti proteins
MOSAIC scholar Katie Dunleavy investigates how Aurora kinase A shields oncogene c-MYC from degradation, using cutting-edge techniques to uncover new strategies targeting “undruggable” molecules.
How HCMV hijacks host cells — and beyond
Ileana Cristea, an ASBMB Breakthroughs webinar speaker, presented her research on how viruses reprogram cell structure and metabolism to enhance infection and how these mechanisms might link viral infections to cancer and other diseases.
Understanding the lipid link to gene expression in the nucleus
Ray Blind, an ASBMB Breakthroughs speaker, presented his research on how lipids and sugars in the cell nucleus are involved in signaling and gene expression and how these pathways could be targeted to identify therapeutics for diseases like cancer.
In memoriam: William S. Sly
He served on the American Society for Biochemistry and Molecular Biology Council in 2005 and 2006 and was an ASBMB member for 35 years.
ASBMB committees welcome new members
Members joined these committees: Education and Professional Development, Maximizing Access, Meetings, Membership, Public Affairs Advisory, Science Outreach and Communication, Student Chapters and Women in Biochemistry and Molecular Biology.